Regenxbio (RGNX) EBT Margin (2014 - 2026)
Regenxbio's EBT Margin came in at 21.01% for Q2 2026, up 352.91 percentage points from -331.91% a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) EBT Margin (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenxbio reported EBT Margin of -93.60%, up 19.20 percentage points year-over-year; for FY2025, it was -113.80%, up 158.74 percentage points from FY2024.
- EBT Margin carries a five-year change of -45.21 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -272.54% in FY2024 (+19.61 pp), -292.15% in FY2023 (-43.40 pp), -248.75% in FY2022 (-278.78 pp) and 30.03% in FY2021 (+98.62 pp).
- The Q2 2026 figure represents the highest quarterly EBT Margin since Q4 2021.
- Year-over-year, EBT Margin increased in five of the last seven quarters, with an average year-over-year change of +105.60 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q1 2025 (a gain of 412.43 percentage points), and the weakest in Q4 2022 (a drop of 268.46 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | 21.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.01% |
| Dec 31, 2025 | -221.40% |
| Sep 30, 2025 | -208.39% |
| Jun 30, 2025 | -331.91% |
| Mar 31, 2025 | 6.81% |
| Dec 31, 2024 | -241.68% |
| Sep 30, 2024 | -246.40% |
| Jun 30, 2024 | -237.80% |
| Mar 31, 2024 | -405.63% |
| Dec 31, 2023 | -283.80% |
| Sep 30, 2023 | -213.97% |
| Jun 30, 2023 | -360.72% |
| Mar 31, 2023 | -348.40% |
| Dec 31, 2022 | -191.35% |
| Sep 30, 2022 | -284.72% |
| Jun 30, 2022 | -208.82% |
| Mar 31, 2022 | -345.50% |
| Dec 31, 2021 | 77.12% |
| Sep 30, 2021 | -189.79% |
| Jun 30, 2021 | -261.58% |
API Access
Regenxbio EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();